Kidney Cancer Linked to Obesity
Study also finds associations between adiposity and 10 other cancers, particularly digestive and hormone-related malignancies.
Diagnosis & Disease Information
Broad-spectrum Antibiotics May Reduce Survival in mRCC
The researchers found that patients treated with ABT had decreased progression-free survival compared with those not receiving ATB.
Biologics Combo Shows Promise As First-Line mRCC Therapy
In a phase 2 trial, atezolizumab plus bevacizumab improved PFS versus sunitinib in patients with renal cell carcinoma expressing PD-L1.
Sunitinib Dose Escalation May Benefit mRCC Patients
Added progression-free survival and prolonged overall survival possible, according to investigators.
Kidney Cancer Brain Metastases Not On the Rise
Researchers develop a model to predict which patients are more likely to harbor brain metastases at cancer diagnosis.
Single RCC Bone Metastasis Predicts Better Survival
Bone surgery should be considered in patients with solitary bone metastasis and no concomitant visceral metastases, according to investigators.
Metabolic Profiles May Distinguish RCC From Benign Masses
In a pilot study, metabolomic analyses of serum and urine showed a high level of predictive ability.
Benign Disease Found in 14% of PN Cases
The most common types of benign pathology were oncocytoma, angiomyolipoma, and complex cysts.
RCC Adjuvant Therapy: Calculating Value
Adjuvant treatments for RCC must be prioritized by physicians because ultimately value is determined by how medicine is practiced.
CB-839 Drug Promising for Clear Cell, Papillary Renal Cell Cancer
In the 15 patients in the study, the dual treatment controlled tumors in 93% of the patients, who had either clear cell or papillary renal cell cancer.
- Loading...
Loading...
Loading... 
Loading...